SHL TelemedicineSHMLF 51 Current Ratio is 1.25 as of Dec. 2025, which is at its 10-year median of 1.25. GuruFocus rates SHMLF with a GF Score™ of 51/100 and a GF Value™ of $13.95. The stock has 3 warning signs investors should review. Among 683 Healthcare Providers & Services companies, SHL Telemedicine ranks worse than 60.47% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. SHL Telemedicine's current ratio for the quarter that ended in Dec. 2025 was 1.25.
SHL Telemedicine has a current ratio of 1.25. It generally indicates good short-term financial strength.
The historical rank and industry rank for SHL Telemedicine's Current Ratio or its related term are showing as below:
SHMLF'
s Current Ratio Range Over the Past 10 Years
Min: 0.84 Med: 1.25 Max: 2.64
Current: 1.25
During the past 13 years, SHL Telemedicine's highest Current Ratio was 2.64. The lowest was 0.84. And the median was 1.25.
SHMLF's Current Ratio is ranked worse than 60.47% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs SHMLF: 1.25
SHL Telemedicine (OTCPK:SHMLF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
SHL Telemedicine Current Ratio Related Terms
SHL Telemedicine Current Ratio Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHMLF vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, SHL Telemedicine's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Current Ratio distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (SHMLF) has a Current Ratio of 1.25 as of Dec. 2025. This is near median its historical median of 1.25. Over the past decade, SHL Telemedicine's Current Ratio has ranged from 0.84 to 2.64. According to the industry distribution chart, SHL Telemedicine ranks #413 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 60.5%.
Is SHL Telemedicine's Current Ratio too high?
SHL Telemedicine's current Current Ratio of 1.25 is near median its 10-year median of 1.25. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 2.64. The Healthcare Providers & Services industry median Current Ratio is 1.47. SHL Telemedicine's value of 1.25 is 15% below this industry median. Based on the distribution chart, SHL Telemedicine ranks #413 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, SHL Telemedicine has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #413 out of 683 companies for Current Ratio. This places SHL Telemedicine in the lower half of its industry. The industry median Current Ratio is 1.47. SHL Telemedicine's value of 1.25 is 15% below this benchmark. Historically, SHL Telemedicine's own Current Ratio has ranged from 0.84 to 2.64 over the past decade. While the company's 10-year median is 1.25 vs. the industry median of 1.47, SHL Telemedicine has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current Current Ratio of 1.25 is 15% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Current Ratio is 1.25, which is near median its own 10-year median of 1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Current Ratio of 1.25. The stock's GF Value™ is $13.95, compared to a current price of $4.84 — trading 65.3% below its estimated fair value. The current Current Ratio is 1.25, which is near median its 10-year median of 1.25 and 15% below the Healthcare Providers & Services industry median of 1.47. SHL Telemedicine's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Current Ratio is 1.25 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (SHMLF) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of $4.84 is trading 65.3% below its estimated GF Value™ of $13.95.
Key valuation signals for SHMLF:
Current Ratio: 1.25 (near median its 10-year median of 1.25)
GF Value™: $13.95 vs. price of $4.84 (65.3% below fair value)
Industry Position: 15% below the Healthcare Providers & Services median (#413 of 683)
No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
51GF Score
Get the complete analysis for SHMLF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHMLF has been successfully added to your 
